IL109770A0 - Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby - Google Patents
Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared therebyInfo
- Publication number
- IL109770A0 IL109770A0 IL10977094A IL10977094A IL109770A0 IL 109770 A0 IL109770 A0 IL 109770A0 IL 10977094 A IL10977094 A IL 10977094A IL 10977094 A IL10977094 A IL 10977094A IL 109770 A0 IL109770 A0 IL 109770A0
- Authority
- IL
- Israel
- Prior art keywords
- dosage forms
- controlled release
- solid dosage
- medicaments
- release solid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939311188A GB9311188D0 (en) | 1993-05-29 | 1993-05-29 | Process |
GB939316252A GB9316252D0 (en) | 1993-08-05 | 1993-08-05 | Process |
GB939318920A GB9318920D0 (en) | 1993-09-11 | 1993-09-11 | Process |
Publications (1)
Publication Number | Publication Date |
---|---|
IL109770A0 true IL109770A0 (en) | 1994-11-28 |
Family
ID=27266706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10977094A IL109770A0 (en) | 1993-05-29 | 1994-05-25 | Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0701436B1 (xx) |
JP (1) | JPH08510752A (xx) |
CN (1) | CN1124452A (xx) |
AP (1) | AP9400645A0 (xx) |
AT (1) | ATE230981T1 (xx) |
AU (1) | AU684522B2 (xx) |
CA (1) | CA2164003A1 (xx) |
DE (1) | DE69432015T2 (xx) |
ES (1) | ES2189803T3 (xx) |
IL (1) | IL109770A0 (xx) |
MA (1) | MA23212A1 (xx) |
NZ (1) | NZ268172A (xx) |
WO (1) | WO1994027557A2 (xx) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
GB9407386D0 (en) | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
GB9416600D0 (en) * | 1994-08-17 | 1994-10-12 | Smithkline Beecham Plc | Pharmaceutical formulation |
IL123563A (en) * | 1995-09-07 | 2002-02-10 | Smithkline Beecham Corp | Pharmaceutical formulations comprising amoxycillin and clavulanate in a weight ratio between 14:1 and 16:1 inclusive |
TWI225402B (en) | 1996-03-13 | 2004-12-21 | Biochemie Gmbh | Auxiliary-free agglomerates |
AT407701B (de) * | 1996-08-12 | 2001-05-25 | Biochemie Gmbh | Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung |
FR2753904B1 (fr) * | 1996-10-01 | 1998-10-30 | Gattefosse Ets Sa | Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication |
IL119627A (en) | 1996-11-17 | 2002-03-10 | Yissum Res Dev Co | PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT |
DE19705538C1 (de) * | 1997-02-14 | 1998-08-27 | Goedecke Ag | Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen |
ES2201468T3 (es) * | 1997-02-14 | 2004-03-16 | Laboratoire Glaxosmithkline S.A.S. | Preparacion farmaceutica que comprende amoxicilina y clavulanato. |
JP2002522354A (ja) * | 1997-09-19 | 2002-07-23 | シャイア ラボラトリーズ,インコーポレイテッド | 固溶体ビードレット |
US6365196B1 (en) * | 1997-10-03 | 2002-04-02 | Smithkline Beecham Corporation | Controlled release solid dosage forms of lithium carbonate |
EP0973520A1 (en) * | 1997-11-17 | 2000-01-26 | Gist-Brocades B.V. | Granules comprising clavulanate and one or more excipients |
HU1500214D0 (hu) * | 1997-12-22 | 2002-03-28 | Euro Celtique Sa | Opioid agonista és antagonista hatóanyagot tartalmazó gyógyszerkészítmény |
AP1224A (en) | 1998-03-19 | 2003-11-14 | Bristol Myers Squibb Co | Biphasic controlled release delivery system for high solubility pharmaceuticals and method. |
DE10017883A1 (de) * | 1999-04-13 | 2000-10-26 | Beecham Pharm Pte Ltd | Neues Behandlungsverfahren |
US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
US7250176B1 (en) | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
US6610328B2 (en) | 2000-02-24 | 2003-08-26 | Advancis Pharmaceutical Corp. | Amoxicillin-clarithromycin antibiotic composition |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6632453B2 (en) | 2000-02-24 | 2003-10-14 | Advancis Pharmaceutical Corp. | Ciprofoxacin-metronidazole antibiotic composition |
AU3986901A (en) * | 2000-02-24 | 2001-09-03 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6627222B2 (en) | 2000-02-24 | 2003-09-30 | Advancis Pharmaceutical Corp. | Amoxicillin-dicloxacillin antibiotic composition |
US6667042B2 (en) | 2000-02-24 | 2003-12-23 | Advancis Pharmaceutical Corp. | Fluroquinilone antibiotic product, use and formulation thereof |
US6991807B2 (en) | 2000-02-24 | 2006-01-31 | Advancis Pharmaceutical, Corp. | Antibiotic composition |
US6623758B2 (en) | 2000-02-24 | 2003-09-23 | Advancis Pharmaceutical Corp. | Cephalosporin-metronidazole antibiotic composition |
US6663891B2 (en) | 2000-02-24 | 2003-12-16 | Advancis Pharmaceutical Corp. | Erythromyacin antibiotic product, use and formulation thereof |
US6565882B2 (en) | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6730320B2 (en) | 2000-02-24 | 2004-05-04 | Advancis Pharmaceutical Corp. | Tetracycline antibiotic product, use and formulation thereof |
US6669948B2 (en) | 2000-02-24 | 2003-12-30 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US7025989B2 (en) | 2000-02-24 | 2006-04-11 | Advancis Pharmaceutical Corp. | Multiple-delayed released antibiotic product, use and formulation thereof |
US6623757B2 (en) | 2000-02-24 | 2003-09-23 | Advancis Pharmaceutical Corp. | Antibiotic composition |
US6667057B2 (en) | 2000-02-24 | 2003-12-23 | Advancis Pharmaceutical Corp. | Levofloxacin antibiotic product, use and formulation thereof |
US6663890B2 (en) | 2000-02-24 | 2003-12-16 | Advancis Pharmaceutical Corp. | Metronidazole antibiotic product, use and formulation thereof |
US7985420B2 (en) | 2000-04-28 | 2011-07-26 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
US7838032B2 (en) | 2000-04-28 | 2010-11-23 | Reckitt Benckiser Inc. | Sustained release of guaifenesin |
US6955821B2 (en) | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
US8012504B2 (en) | 2000-04-28 | 2011-09-06 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
WO2002030392A2 (en) | 2000-10-12 | 2002-04-18 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
US6541014B2 (en) | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US7105174B2 (en) | 2000-10-13 | 2006-09-12 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-neoplastic product, use and formulation thereof |
US7074417B2 (en) | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
US7157095B2 (en) | 2000-10-13 | 2007-01-02 | Advancis Pharmaceutical Corporation | Multiple-delayed release antifungal product, use and formulation thereof |
US20020197314A1 (en) | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
AT413015B (de) * | 2001-04-12 | 2005-10-15 | Sandoz Ag | Tablette enthaltend das k-salz der 3-(2-hydroxyethyliden)-7-oxo-4-oxa-1- azabicyclo(3.2.0)heptan-2 carbonsäure in hydrophobisierter form |
GB0209265D0 (en) * | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
WO2004078164A1 (en) * | 2003-03-04 | 2004-09-16 | Nostrum Pharmaceuticals, Inc. | Control release formulation containing a hydrophobic material as the sustained release agent |
JP2007502294A (ja) | 2003-08-12 | 2007-02-08 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
BRPI0417348A (pt) * | 2003-12-04 | 2007-03-13 | Pfizer Prod Inc | processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo |
CN1889931A (zh) * | 2003-12-04 | 2007-01-03 | 辉瑞产品公司 | 利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾-冻凝方法 |
PE20060652A1 (es) * | 2004-08-27 | 2006-08-11 | Novartis Ag | Composiciones farmaceuticas de liberacion inmediata que comprenden granulos de fusion |
CN101014578B (zh) | 2004-09-16 | 2011-01-19 | 安斯泰来制药有限公司 | ***衍生物或其盐 |
MY161846A (en) | 2010-07-09 | 2017-05-15 | James Trinca Green | Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
GB201420311D0 (en) * | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Pharmaceutical processing |
GB201420306D0 (en) | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Compositions |
US11278506B2 (en) | 2015-10-09 | 2022-03-22 | Rb Health (Us) Llc | Pharmaceutical formulation |
CN114072493A (zh) | 2019-07-05 | 2022-02-18 | 葛兰素史密斯克莱知识产权(第2 号)有限公司 | 棒状链霉菌 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4132753A (en) * | 1965-02-12 | 1979-01-02 | American Cyanamid Company | Process for preparing oral sustained release granules |
JPS56140915A (en) * | 1980-04-07 | 1981-11-04 | Yamanouchi Pharmaceut Co Ltd | Pharmaceutical preparation for solid drug |
US5169645A (en) * | 1989-10-31 | 1992-12-08 | Duquesne University Of The Holy Ghost | Directly compressible granules having improved flow properties |
-
1994
- 1994-05-25 IL IL10977094A patent/IL109770A0/xx unknown
- 1994-05-26 CA CA002164003A patent/CA2164003A1/en not_active Abandoned
- 1994-05-26 AU AU70962/94A patent/AU684522B2/en not_active Ceased
- 1994-05-26 AT AT94920040T patent/ATE230981T1/de not_active IP Right Cessation
- 1994-05-26 EP EP94920040A patent/EP0701436B1/en not_active Expired - Lifetime
- 1994-05-26 CN CN94192262A patent/CN1124452A/zh active Pending
- 1994-05-26 NZ NZ268172A patent/NZ268172A/en unknown
- 1994-05-26 DE DE69432015T patent/DE69432015T2/de not_active Expired - Fee Related
- 1994-05-26 JP JP7500960A patent/JPH08510752A/ja active Pending
- 1994-05-26 AP APAP/P/1994/000645A patent/AP9400645A0/en unknown
- 1994-05-26 WO PCT/US1994/005930 patent/WO1994027557A2/en active IP Right Grant
- 1994-05-26 ES ES94920040T patent/ES2189803T3/es not_active Expired - Lifetime
- 1994-05-27 MA MA23523A patent/MA23212A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AU684522B2 (en) | 1997-12-18 |
WO1994027557A3 (en) | 1995-03-16 |
MA23212A1 (fr) | 1994-12-31 |
DE69432015D1 (de) | 2003-02-20 |
ES2189803T3 (es) | 2003-07-16 |
DE69432015T2 (de) | 2003-11-06 |
EP0701436A4 (en) | 1997-05-21 |
WO1994027557A2 (en) | 1994-12-08 |
EP0701436B1 (en) | 2003-01-15 |
NZ268172A (en) | 1997-12-19 |
AP9400645A0 (en) | 1994-07-31 |
ATE230981T1 (de) | 2003-02-15 |
CN1124452A (zh) | 1996-06-12 |
AU7096294A (en) | 1994-12-20 |
JPH08510752A (ja) | 1996-11-12 |
CA2164003A1 (en) | 1994-12-08 |
EP0701436A1 (en) | 1996-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL109770A0 (en) | Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby | |
HUT70157A (en) | Imidazolylalcenoic acids, pharmaceutical compositions containing them, and process for producing them, and use of them for preparing medicaments | |
HK12395A (en) | Formulation for preparing sustained release drugs for oral administration | |
IL115646A (en) | Medicinal and/or nutritional microcapsules for oral administration process for their preparation and galenical system containing them | |
HUT59314A (en) | Process for producing pharmaceutical composition comprising minocylcine active ingredient and suitable for a single daily administration | |
HRP920229A2 (en) | Release of medicinal substances and preparation process therefor | |
HUP9903734A3 (en) | Controlled-release pharmaceutical formulations for oral administration and method for preparing this | |
AU2964692A (en) | Method and apparatus for preprogrammed infusion of iv medicaments | |
ZA849373B (en) | Method and composition for the preparation of controlled longacting pharmaceuticals for oral administration | |
PT77503A (en) | Process for preparing pharmaceutical compositions for oral and/or enteral administration | |
PL265416A1 (en) | A pharmaceutical preparation for oral administration and a method of its production | |
EP0729748A4 (en) | METHOD FOR PRODUCING STABLE MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATION | |
IL191582A (en) | Process for preparing a pharmaceutical composition containing Ritonbir and use of Britonbir crystalline form ii for the preparation of a drug | |
NZ229518A (en) | Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment | |
EP0582169A3 (en) | Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form | |
AU2782592A (en) | Thermal enhancement of transdermal drug administration | |
HUT59319A (en) | Pharmaceutical compositions with controlled release of active ingredient and process for producing same | |
ZA87216B (en) | A pharmaceutical composition with sustained release of the active component and a process for the preparation thereof | |
AU3721293A (en) | Pharmaceutical preparation for sustained release of a drug and process for producing the same | |
EP0409893A4 (en) | Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration | |
AR244243A1 (es) | Procedimiento para preparar timolinfotropina. | |
HUP9801947A3 (en) | Device and process for mixing a pharmaceutical composition with another agent and method for oral administration of the pharmaceutical preparation | |
GB8801863D0 (en) | Pharmaceutical formulations with controlled drug release | |
IL116615A0 (en) | A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of salts thereof | |
ZA943736B (en) | A thermal infusion process for preparing controlled release solid dosage forms of medicaments |